Citizens & Northern Corp’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-5,301
Closed -$888K 107
2019
Q2
$888K Sell
5,301
-73
-1% -$10.1K 0.49% 59
2019
Q1
$787K Buy
5,374
+2,439
+83% +$354K 0.44% 64
2018
Q4
$392K Sell
2,935
-1,368
-32% -$224K 0.27% 82
2018
Q3
$820K Buy
+4,303
New +$790K 0.56% 63
2017
Q4
Sell
-8,295
Closed -$1.7M 99
2017
Q3
$1.7M Buy
8,295
+143
+2% +$33.3K 1.29% 23
2017
Q2
$1.98M Sell
8,152
-213
-3% -$50.1K 1.56% 14
2017
Q1
$2M Buy
8,365
+108
+1% +$25.2K 1.61% 13
2016
Q4
$1.73M Buy
8,257
+472
+6% +$97.8K 1.31% 21
2016
Q3
$1.79M Buy
7,785
+1,811
+30% +$443K 1.41% 17
2016
Q2
$1.38M Buy
+5,974
New +$1.38M 1.08% 33

Other funds holding AGN

Citizens & Northern Corp's AGN Position: Q3 2019 in Review

Citizens & Northern Corp sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 5,301 shares — an estimated $888K sold.

Citizens & Northern Corp first reported a position in AGN in Q2 2016 and held it in 10 quarters. The position peaked at $2M in Q1 2017. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Citizens & Northern Corp reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • Citizens & Northern Corp sold 5,301 Allergan plc shares in Q3 2019, an estimated $888K.
  • Citizens & Northern Corp first reported a position in Allergan plc in Q2 2016 and held it in 10 quarters.
  • Citizens & Northern Corp's Allergan plc position peaked at $2M in Q1 2017.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Citizens & Northern Corp's 13F filing for Q3 2019, filed 12 Nov 2019.